Kuano
London · Founded 2020
About Kuano
Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Funding stage: Seed
- Last round: Seed (Sep 2023)
- Website: https://www.kuano.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/kuano-115154 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.